Health, Longevity & Biohacking
Two-Thirds of GLP-1 Users Stop Within One Year Due to Side Effects
ZOE Science & Nutrition
The 4 rules to protect your muscle, bones and brain health when using Ozempic and other weight loss injections | Dr Federica Amati
"Depending on which study you look at, it's about 50 to 60% of people stop taking the drug within a year. In some analyses, it's two-thirds of people stop because they can't tolerate the side effects or because they can't afford to keep paying out of pocket for it."
Real-world data shows a massive dropout rate among Ozempic and Mounjaro users, with most stopping due to gastrointestinal side effects that could be managed through proper dietary intervention. The revelation highlights a critical gap between the drugs' promise and their practical application, particularly for those accessing them outside traditional medical supervision.
From this episode
ZOE Science & Nutrition